Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.
15 May 2020 11:46 AM
Biktarvy is once-daily tablet combining emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir.
30 Apr 2018 9:57 AM
However, rival ViiV Healthcare, quickly filed a lawsuit alleging that Gilead was infringing patents on ViiV’s dolutegravir.
08 Feb 2018 9:54 AM